Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 21

dr.

Taufiqur Rahman, SpA RS Muhammadiyah Lamongan


1

Pendahuluan
Hepatitis inflamasi dan atau nekrosis hati

Penyebab:
Infeksi paling sering Obat Toxin Autoimun Gangguan metabolik

Hepatitis Infeksi:
Virus paling sering Bakteri Parasit
2

Virus Hepatitis A

DIAGNOSIS
Anamnesis:
Gx prodromal: anoreksia, mual, muntah & demam
Ikterus, tinja pucat, urine berwarna gelap Riwayat kontak dengan penderita hepatitis Riwayat minum obat2an

Pemeriksaan Fisik:
KU: sebagian besar sakit ringan Kulit, sklera ikterik

Nyeri tekan di daerah hati, hepatomegali

Pemeriksaan penunjang
DL Bisa ditemukan pansitopenia atau

leukositosis UL Bilirubin urin LFT Serologi


Ig M anti HAV HBs Ag, IgM anti HBc, Anti HDV, Anti HCV

USG Abdomen

TERAPI
Terapi SUPPORTIF:
bed rest, diet tinggi kalori, hindari obat2 hepatotoksik

Medikamentosa
Ursodeoxycholic acid Obat anti virus: interveron, lamivudine, ribavirine Prednisone jika perlu

HEPATITIS B
Modes Of Transmission Perinatal infection Blood Transfusion Horizontal transmission Sexual transmission Intravenous drug use / percutaneous inoculation. Nosocomial Organ transplantation-Anti-HBc screening

10

Hepatitis B - Clinical Features


Incubation period: Clinical illness (jaundice): Average 60-90 days

Range 45-180 days


<5 yrs: 5 yrs: <10% 30%-50% 30%-90% 2%-10%

Acute case-fatality rate:


Chronic infection:

0.5%-1%
<5 yrs: 5 yrs: 15%-25%

Premature mortality from


chronic liver disease:
11

Serology test
Lab. Test
HBsAg HBeAg Anti HBs Anti HBc IgM anti HBc

Interpretation
Current infection Active replication highly infectious Resolution Current or previous infection Acute or reactivation of chronic Resolution of active replication

Clinical syndrome
Acute, CAH, Carrier Acute, CAH Immunity Acute, Chronic, Carrier, Immunity Acute, CAH

Anti HBe
12

Carrier, Immunity

Immunological events of acute HBV infection


A) Acute

B) Chronic

Engleberg, et. al., Schaechters Mechanisms of Microbial Disease, Fourth Edition, Chapter 43, published by Lippincott Williams & Wilkins, Philadelphia.

13

Clinical outcomes of Hepatitis B infections

14

Clinical outcomes of acute hepatitis B infection. (Redrawn from White DO, Fenner F: Medical virology, ed 3, New York, 1986, Academic Press
From Murray et. al., Medical Microbiology 5th edition, 2005, Chapter 62, published by Mosby Philadelphia,,

Risk of chronic HBV by age of acquisition and immune status

Seorang bayi dilahirkan oleh ibu yang pada pemeriksaan kehamilan trimester ketiga diketahui

dengan HBsAg yang positif

16

Tindakan apa yang kita lakukan pada bayi

tersebut:

Imunisasi pasif? Imunisasi aktif?

17

Recommended schedule of hepatitis B immunoprophylaxis to prevent perinatal transmission of hepatitis B virus infection Infant born to mother known to be HBsAg positive

Vaccine dose
First HBIG Second Third

Age of infant
Birth (within 12 hours) Birth (within 12 hours) 1 month 6 months

http://www.cdc.gov/ncidod/diseases/hepatitis 18

19

TATALAKSANA KHUSUS SESUDAH PERIODE PERINATAL Pemeriksaan anti HBs dan HbsAg berkala pada usia

7 bulan (1bulan setelah vaksin hepatitis B ketiga) 1, 3, 5 tahun setiap 1 tahun


Bila usia 7 bulan

* anti HBs positif,periksa ulang anti HBs dan HBsAg pada usia 1,3, 5 dan 10 tahun

* anti HBs dan HBsAg negatif, beri satu kali tambahan dosis vaksinasi 1 bulan kmd ulang anti HBs. Bila anti HBs positif, periksa ulangpada usia 1, 3, dan 5 tahun dan 10 tahun

You might also like